BDBM164211 US9688615, 22

SMILES NCC(=O)NCc1nc2cc(Cl)c(Cl)cc2[nH]1

InChI Key InChIKey=PUOWNSGONWNIDT-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 164211   

TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164211(US9688615, 22)
Affinity DataIC50: 1.00E+4nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetVoltage-dependent N-type calcium channel subunit alpha-1B(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164211(US9688615, 22)
Affinity DataIC50: 1.00E+4nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1G(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164211(US9688615, 22)
Affinity DataIC50: 7.52E+3nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164211(US9688615, 22)
Affinity DataIC50: 1.00E+4nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetVoltage-dependent T-type calcium channel subunit alpha-1H(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164211(US9688615, 22)
Affinity DataIC50: 1.00E+4nMAssay Description:Cells were plated in 384-well, clear-bottom, black-walled, poly-D-lysine coated plates (Becton Dickinson, Franklin Lake, N.J.) 2 days prior to use in...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetVoltage-dependent L-type calcium channel subunit alpha-1C(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164211(US9688615, 22)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:To assess the potential cardiac liability of compounds at an early stage in the drug discovery process, a Nav1.5 sodium channel screening assay was b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetVoltage-dependent L-type calcium channel subunit alpha-1C(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164211(US9688615, 22)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:To assess the potential cardiac liability of compounds at an early stage in the drug discovery process, a Nav1.5 sodium channel screening assay was b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent

TargetSodium channel protein type 5 subunit alpha(Human)
Degiacomo, Interim Trustee, Mark G.

US Patent
LigandPNGBDBM164211(US9688615, 22)
Affinity DataIC50: 1.00E+4nMpH: 7.4Assay Description:To assess the potential cardiac liability of compounds at an early stage in the drug discovery process, a Nav1.5 sodium channel screening assay was b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2018
Entry Details
US Patent